Found 18 matching trials
ADV-TK Improves Outcome of Recurrent High-Grade Glioma PHASE2 Malignant gliomas are the most common primary brain tumor in adults, but th...
Show More Location
Beijing YouAn Hospital
Learn More & Join Trial
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma PHASE2 HCC patients with tumors \>5 cm in diameter, regardless of involvement in t...
Show More Location
Multiple Locations
Learn More & Join Trial
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec PHASE2 Phase 2a, open-label, multi-center study evaluating biomarkers and biodistr...
Show More Location
Academic Urology and Urogynecology of Arizona
Learn More & Join Trial
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) PHASE2 The purpose of this study is to evaluate the effectiveness of CAN-2409 immu...
Show More Status
Active Not Recruiting
Location
Foothills Urology
Learn More & Join Trial
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors PHASE1 This study will evaluate the administration of AdV-tk followed by valacyclo...
Show More Location
Ann & Robert H. Lurie Children's Hospital of Chicago (Formerly Children's Memorial Hospital)
Learn More & Join Trial
Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer PHASE1 This is a phase I dose escalation study of CAN-2409 plus prodrug in patient...
Show More Location
University of Pennsylvania
Learn More & Join Trial
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery PHASE2 This is a prospective phase II study to assess the efficacy and toxicity of...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA) PHASE3 This phase III trial compares the effect of the combination of aglatimagene...
Show More Location
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
Learn More & Join Trial
Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion PHASE1 This is a phase I study of intrapleural AdV-tk therapy in patients with mal...
Show More Location
University of Pennsylvania
Learn More & Join Trial
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC PHASE2 The purpose of this clinical trial is to evaluate the effects of adding CAN...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital
Learn More & Join Trial